Tangen Biosciences
Branford, US · Founded 2013
Biotech
Founders & leadership
JR
John Richard NobileExecutive Officer, Director, Promoter
JR
John Richard DavidsonExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements$464.8KraisedJun 2023 · 9 investors · Biotechnology
Rule 506(b)$11.2MraisedJul 2020 · 39 investors · Biotechnology
Rule 506(b)$6.7MraisedMar 2019 · 29 investors · Biotechnology
Rule 506(b)$8MofferedNov 2016 · Biotechnology
Rule 506(c)$2MraisedDec 2015 · 8 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.